Network Analysis Shows Novel Molecular Mechanisms of Action for Copper-Based Chemotherapy

about

Network Analysis Shows Novel Molecular Mechanisms of Action for Copper-Based Chemotherapy

Item

http://www.wikidata.org/entity/Q36453015

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Network Analysis Shows Novel Molecular Mechanisms of Action for Copper-Based Chemotherapy

@ast

Network Analysis Shows Novel Molecular Mechanisms of Action for Copper-Based Chemotherapy

@en

type

Item

label

Network Analysis Shows Novel Molecular Mechanisms of Action for Copper-Based Chemotherapy

@ast

Network Analysis Shows Novel Molecular Mechanisms of Action for Copper-Based Chemotherapy

@en

prefLabel

Network Analysis Shows Novel Molecular Mechanisms of Action for Copper-Based Chemotherapy

@ast

Network Analysis Shows Novel Molecular Mechanisms of Action for Copper-Based Chemotherapy

@en

P1476

Network Analysis Shows Novel Molecular Mechanisms of Action for Copper-Based Chemotherapy

@en

P2093

Jesús Espinal-Enríquez

http://www.w3.org/2001/XMLSchema#string

Lena Ruiz-Azuara

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Hallmarks of Cancer: The Next Generation

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

Pathway Analysis: State of the Art

CDK inhibitors: positive and negative regulators of G1-phase progression

Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells

Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice

Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM.

Hydroxychloroquine inhibits autophagy to potentiate antiestrogen responsiveness in ER+ breast cancer.

Cross-talk between HER2 and MED1 regulates tamoxifen resistance of human breast cancer cells.

P304

406

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHYS.2015.00406

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Carmen Mejía

Enrique Hernández-Lemus

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

290220794

http://www.w3.org/2001/XMLSchema#string

P698

26793116

http://www.w3.org/2001/XMLSchema#string

P932

4709449

http://www.w3.org/2001/XMLSchema#string